Abstract
The authors treated 188 patients with osteosarcoma by chemotherapy followed by surgery and additional chemotherapy (Rosen's T regimen). In 14% of cases, infectious, neurologic or cardiac complications were observed, which resulted in death in 2% of the patients. Forty-six per cent responded well to the primary chemotherapy, 76% of which are alive and disease-free, as opposed to merely 42% of the bad responders.
MeSH terms
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Bone Neoplasms / drug therapy*
-
Bone Neoplasms / surgery
-
Child
-
Child, Preschool
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Dactinomycin / administration & dosage
-
Doxorubicin / administration & dosage
-
Drug Administration Schedule
-
Female
-
Humans
-
Male
-
Methotrexate / administration & dosage
-
Middle Aged
-
Osteosarcoma / drug therapy*
-
Osteosarcoma / surgery
-
Prognosis
Substances
-
Bleomycin
-
Dactinomycin
-
Doxorubicin
-
Cyclophosphamide
-
Cisplatin
-
Methotrexate